These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38495124)

  • 1. Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson's Disease Psychosis.
    Rajagopalan K; Rashid N; Yakkala V; Doshi D
    Clinicoecon Outcomes Res; 2024; 16():149-159. PubMed ID: 38495124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis.
    Rajagopalan K; Rashid N; Doshi D
    J Comp Eff Res; 2024 Jan; 13(1):e230114. PubMed ID: 38099518
    [No Abstract]   [Full Text] [Related]  

  • 3. Health care resource utilization patterns among patients with Parkinson's disease psychosis: analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.
    Rajagopalan K; Rashid N; Kumar S; Doshi D
    J Med Econ; 2023; 26(1):34-42. PubMed ID: 36444507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients treated with pimavanserin or quetiapine for Parkinson's disease psychosis: analysis of health resource utilization patterns among Medicare beneficiaries.
    Rajagopalan K; Rashid N; Doshi D
    J Med Econ; 2023; 26(1):769-776. PubMed ID: 37272069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.
    Rajagopalan K; Rashid N; Gopal D; Doshi D
    J Comp Eff Res; 2024 Jul; 13(7):e240038. PubMed ID: 38850129
    [No Abstract]   [Full Text] [Related]  

  • 6. Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis.
    Rajagopalan K; Rashid N; Gopal D; Doshi D
    Drugs Real World Outcomes; 2024 Sep; 11(3):441-449. PubMed ID: 38914856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries.
    Rajagopalan K; Rashid N; Gopal D; Doshi D
    Int J Geriatr Psychiatry; 2023 Nov; 38(11):e6017. PubMed ID: 37936540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study.
    Layton JB; Forns J; McQuay LJ; Danysh HE; Dempsey C; Anthony MS; Turner ME
    Drug Saf; 2023 Feb; 46(2):195-208. PubMed ID: 36517664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Therapy Utilization at Skilled Nursing Facilities Under Medicare's Patient Driven Payment Model.
    Zhang W; Luck J; Patil V; Mendez-Luck CA; Kaiser A
    J Am Med Dir Assoc; 2022 Nov; 23(11):1765-1771. PubMed ID: 35810791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falls and Fractures in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study.
    Layton JB; Forns J; Turner ME; Dempsey C; Bartsch JL; Anthony MS; Danysh HE; Ritchey ME; Demos G
    Drugs Real World Outcomes; 2022 Mar; 9(1):9-22. PubMed ID: 34718963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson's Disease Psychosis: Systematic Review and Network Meta-Analysis.
    Yunusa I; Rashid N; Seyedin R; Paratane D; Rajagopalan K
    J Geriatr Psychiatry Neurol; 2023 Sep; 36(5):417-432. PubMed ID: 36720473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data.
    Kumar A; Rahman M; Trivedi AN; Resnik L; Gozalo P; Mor V
    PLoS Med; 2018 Jun; 15(6):e1002592. PubMed ID: 29944655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release.
    Rajagopalan K; O'Day K; Meyer K; Pikalov A; Loebel A
    J Med Econ; 2013 Aug; 16(8):987-96. PubMed ID: 23742620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simple Physical Therapy Algorithm Is Successful in Decreasing Skilled Nursing Facility Length of Stay and Increasing Cost Savings After Hip Fracture With No Increase in Adverse Events.
    Adrados M; Wang K; Deng Y; Bozzo J; Messina T; Stevens A; Moore A; Morris J; O'Connor MI
    Geriatr Orthop Surg Rehabil; 2021; 12():2151459321998615. PubMed ID: 33815865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rehabilitation costs: implications for prospective payment.
    Schlenker RE; Kramer AM; Hrincevich CA; Eilertsen TB
    Health Serv Res; 1997 Dec; 32(5):651-68. PubMed ID: 9402906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.
    Isaacson SH; Pahwa R; Pagan F; Abler V; Truong D
    Clin Park Relat Disord; 2024; 10():100256. PubMed ID: 38770047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Postacute Care in the Medicare Shared Savings Program.
    McWilliams JM; Gilstrap LG; Stevenson DG; Chernew ME; Huskamp HA; Grabowski DC
    JAMA Intern Med; 2017 Apr; 177(4):518-526. PubMed ID: 28192556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Skilled Nursing Facility Ownership by Health Care Networks With Utilization and Spending.
    Kalata S; Howard R; Diaz A; Nuliyahu U; Ibrahim AM; Nathan H
    JAMA Netw Open; 2023 Feb; 6(2):e230140. PubMed ID: 36808240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.